Kim, Y., & Shin, D. (2023). CLINICAL RESULTS OF LONG-TERM LOBEGLITAZONE ADD-ON THERAPY IN TYPE 2 DIABETES. Journal of the ASEAN Federation of Endocrine Societies, 38(S3), 71–72. Retrieved from https://asean-endocrinejournal.org/index.php/JAFES/article/view/3393